MedTrace Logo

Sphenopalatine Ganglion Block for Postdural Puncture Headache

NCT04892290 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2021-05-19

No results posted yet for this study

Summary

Background: Postdural puncture headache (PDPH), which is one of the complications of spinal anesthesia, is a condition that negatively affects the quality of life of patients, causes late mobilization and prolonged hospital stay. Sphenopalatine ganglion block (SGB) has created a minimally invasive, easy, and safe treatment alternative.

Objective: Evaluating the effectiveness of topical SGB on PDPH treatment. Design: Retrospective observational study Setting: Single center tertiary level of care hospital study. The files of PDPH patients between Jan 2018 and Jan 2020 were scanned.

Patients: PDPH patients aged 18-65 are included and any patients with primary/secondary headache history are excluded.

Main outcome measures: Patients were divided into 2 groups. The group that given only conservative treatment was named as Group C, and the group of patients who had additionally been applied SGB was named as Group SGB. Headache severity was measured with Visual Analogue Scale (VAS) at the 1st,3rd, 12th and 24th hours of the treatment, in supine and upright position.

Conditions

  • Postdural Puncture Headache

Interventions

OTHER

Conservative Treatment for Postdural Puncture Headache

The patients in Group C were given continuous bed rest in the supine position, 3000 mL daily hydration, 6 mg kg-1 aminophylline , 2 g day-1 paracetamol and 65 mg day-1 caffeine as conservative treatment. Topical SGB was applied to patients in Group SGB in addition to conservative treatment.

Sponsors & Collaborators

  • Sakarya University

    lead OTHER

Principal Investigators

  • Burak Kaya, MD · Sakarya University

  • Serbülent Gökhan Beyaz, Prof MD · Istinye University

  • Ayça Taş Tuna, As Prof MD · Sakarya University

  • Havva Kocayiğit, MD · Sakarya University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-01
Primary Completion
2020-04-30
Completion
2020-05-19

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04892290 on ClinicalTrials.gov